Treatment of Huntington's Disease
AssigneeGenix Therapeutics Group, LLC
InventorRagab El-Rashidy
Life of this patent
Estimating the term…
Abstract
The present invention relates to a method of treatment and/or ameliorating the symptoms of Huntington's disease comprising the step of administering an effective amount of adenosine triphosphate, co-carboxylase, nicotinamide, and cyanocobalamin in a physiologically acceptable carrier to an individual in need thereof. Preferably, the administration is via intramuscular injection.
Claims5
A method for ameliorating the symptoms of Huntington's Disease which comprises administering to a patient exhibiting symptoms of Huntington's Disease an effective amount of a composition comprising adenosine triphosphate, co-carboxylase, nicotinamide, and cyanocobalamin in a physiologically acceptable carrier.
Dependencies are inferred from the claim text.